|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...28293031323334353637383940» |
- Trial completion: Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users (clinicaltrials.gov) - Sep 2, 2012
P2, N=1683, Completed, Sponsor: Oregon Research Institute
Active, not recruiting --> Completed
- Enrollment closed: Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence (clinicaltrials.gov) - Aug 29, 2012
P2/3, N=20, Active, not recruiting, Sponsor: Elizabeth Ralevski
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: Pilot Study of Text Message Brief Interventions for Problem Drinkers (clinicaltrials.gov) - Aug 28, 2012
P=N/A, N=91, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting N=210 --> 91
- || acetylcysteine solution / Generic mfg.
New P3 trial: ACCENT: Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (clinicaltrials.gov) - Aug 28, 2012
P3, N=300, Recruiting, Sponsor: Medical University of South Carolina
- Trial completion: Pilot Study of Text Message Brief Interventions for Problem Drinkers (clinicaltrials.gov) - Aug 28, 2012
P=N/A, N=91, Completed, Sponsor: Centre for Addiction and Mental Health
N=210 --> 91 Active, not recruiting --> Completed
- Buprenex (buprenorphine) / Reckitt Benckiser
New P1 trial: MOPPlus: Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines (clinicaltrials.gov) - Aug 21, 2012
P1, N=40, Recruiting, Sponsor: Thomas Jefferson University
- Enrollment closed: Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial (clinicaltrials.gov) - Aug 21, 2012
P=N/A, N=80, Active, not recruiting, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Clinical: FAST-PRI: Functional Assessment Screening Patient Reported Information (clinicaltrials.gov) - Aug 19, 2012
P=N/A, N=1701, Not yet recruiting, Sponsor: University of Pittsburgh
- | galantamine extended release / Generic mfg.
New P2 trial: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Aug 19, 2012
P2, N=80, Recruiting, Sponsor: University of Pennsylvania
- Biomarker: Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts (clinicaltrials.gov) - Aug 16, 2012
P=N/A, N=600, Recruiting, Sponsor: National Health Research Institutes, Taiwan
- quetiapine / Generic mfg.
Trial completion: An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence (clinicaltrials.gov) - Aug 15, 2012
P4, N=100, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| Bunavail (buprenorphine/naloxone transmucosal) / Collegium Pharma
New P2 trial: An Open Label Study To Assess The Safety And Tolerability Of BEMA (clinicaltrials.gov) - Aug 14, 2012
P2, N=249, Completed, Sponsor: BioDelivery Sciences International
- Enrollment open: Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine (clinicaltrials.gov) - Aug 12, 2012
P=N/A, N=16, Recruiting, Sponsor: William Stoops
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | trazodone ER / Generic mfg., quetiapine / Generic mfg.
New P4 trial: Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans (clinicaltrials.gov) - Aug 8, 2012
P4, N=122, Enrolling by invitation, Sponsor: VA Connecticut Healthcare System
- Clinical: Routine Clinical Screening for Substance Use Disorders in the Emergency Room Setting (clinicaltrials.gov) - Aug 7, 2012
P=N/A, N=10000, Enrolling by invitation, Sponsor: University of Alabama at Birmingham
- Enrollment change: Family Intervention for Mental Illness and Substance Abuse (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=108, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Not yet recruiting --> Recruiting N=140 --> 108
- | New P2 trial: CALM: Couples Therapy for Alcoholic Patients (clinicaltrials.gov) - Aug 6, 2012
P2, N=320, Recruiting, Sponsor: Harvard University
- | Chantix (varenicline) / Pfizer
Trial completion: STOP: Smoking Termination Opportunity for inPatients (clinicaltrials.gov) - Aug 6, 2012
P2/3, N=392, Completed, Sponsor: The Queen Elizabeth Hospital
N=140 --> 108 Active, not recruiting --> Completed
- Trial completion: Family Intervention for Mental Illness and Substance Abuse (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=108, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- modafinil / Generic mfg.
Enrollment change: Modafinil, Sleep, and Cognition in Cocaine Dependence (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=44, Completed, Sponsor: Yale University
Active, not recruiting --> Completed N=36 --> 44
- modafinil / Generic mfg.
Trial completion: Modafinil, Sleep, and Cognition in Cocaine Dependence (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=44, Completed, Sponsor: Yale University
N=36 --> 44 Recruiting --> Completed
- Clinical: Family-Based Treatment for Parental Substance Abuse and Child Maltreatment (clinicaltrials.gov) - Aug 1, 2012
P=N/A, N=240, Recruiting, Sponsor: Medical University of South Carolina
- Enrollment change: Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=63, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed N=120 --> 63
- Trial completion: Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=63, Completed, Sponsor: University of Pennsylvania
N=120 --> 63 Active, not recruiting --> Completed
- Trial completion: Identification of New Serum Markers for Detection of Abuse With Erythropoietin (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=35, Completed, Sponsor: University of Aarhus
Active, not recruiting --> Completed Recruiting --> Completed
- citicoline / Generic mfg.
Trial completion: Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence (clinicaltrials.gov) - Jul 30, 2012
P4, N=130, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: PTSC: Persistence-Targeted Smoking Cessation (clinicaltrials.gov) - Jul 29, 2012
P1, N=50, Recruiting, Sponsor: Rutgers, The State University of New Jersey
- ||| diazepam / Generic mfg.
Clinical: Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=1000, Active, not recruiting, Sponsor: University of Pittsburgh
- pramipexole IR / Generic mfg.
New P1 trial: Pramipexole as a Treatment for Cocaine Dependence (clinicaltrials.gov) - Jul 25, 2012
P1, N=11, Recruiting, Sponsor: Baylor College of Medicine
- cabergoline / Generic mfg.
New P1 trial: A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence (clinicaltrials.gov) - Jul 25, 2012
P1, N=11, Completed, Sponsor: Baylor College of Medicine
- | Lucemyra (lofexidine) / US WorldMeds, Stada
New P1 trial: Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients (clinicaltrials.gov) - Jul 24, 2012
P1, N=27, Completed, Sponsor: US WorldMeds LLC
- naltrexone / Generic mfg.
Trial completion: Medication Development in Alcoholism: Acamprosate Versus Naltrexone (clinicaltrials.gov) - Jul 18, 2012
P2, N=62, Completed, Sponsor: The Scripps Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Gabapentin Treatment of Alcohol Dependence (clinicaltrials.gov) - Jul 18, 2012
P1/2, N=150, Completed, Sponsor: The Scripps Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Enrollment change: Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure (clinicaltrials.gov) - Jul 17, 2012
P3, N=200, Recruiting, Sponsor: Vital Therapies, Inc.
Active, not recruiting --> Completed N=152 --> 200
- buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
New P1 trial: Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance (clinicaltrials.gov) - Jul 15, 2012
P1, N=100, Recruiting, Sponsor: Johns Hopkins University
- ||| Chantix (varenicline) / Pfizer
Trial completion: Denic: De-nicotinised Cigarettes Study (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=200, Completed, Sponsor: Queen Mary University of London
N=152 --> 200 Active, not recruiting --> Completed
- | New P2 trial: BRAC: Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (clinicaltrials.gov) - Jul 12, 2012
P2, N=60, Active, not recruiting, Sponsor: University of Cincinnati
- |||| Enrollment open: Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis (clinicaltrials.gov) - Jul 11, 2012
P2, N=60, Recruiting, Sponsor: Stempeutics Research Pvt Ltd
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis (clinicaltrials.gov) - Jul 10, 2012
P1, N=50, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Recruiting N=30 --> 50
- naltrexone / Generic mfg.
New P4 trial: Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers (clinicaltrials.gov) - Jul 9, 2012
P4, N=2, Terminated, Sponsor: Centre for Addiction and Mental Health
- ||||||| Trial completion: Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction (clinicaltrials.gov) - Jul 9, 2012
P2/3, N=81, Completed, Sponsor: Mayo Clinic
N=30 --> 50 Active, not recruiting --> Completed
- propranolol / Generic mfg.
New P2 trial: Memory Reconsolidation Blockade for Treating Drug Addiction (clinicaltrials.gov) - Jul 4, 2012
P2, N=45, Recruiting, Sponsor: Douglas Mental Health University Institute
- quetiapine / Generic mfg.
Enrollment closed: Seroquel for Frequent, Heavy Drinkers (clinicaltrials.gov) - Jul 4, 2012
P2, N=180, Active, not recruiting, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: Testing Counseling Styles to Motivate Smokers to Quit (clinicaltrials.gov) - Jul 2, 2012
P3, N=255, Completed, Sponsor: University of Missouri, Kansas City
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- topiramate / Generic mfg.
Enrollment open: Topiramate to Aid Smoking Cessation in Alcohol Dependent Men (clinicaltrials.gov) - Jun 28, 2012
P2, N=150, Recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- Enrollment change: The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients (clinicaltrials.gov) - Jun 27, 2012
P2, N=333, Completed, Sponsor: Wake Forest Baptist Health
Active, not recruiting --> Recruiting N=514 --> 333
- | pioglitazone / Generic mfg.
New P2 trial: Role of Proinflammatory Signaling in Alcohol Craving (clinicaltrials.gov) - Jun 27, 2012
P2, N=60, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Trial completion: The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients (clinicaltrials.gov) - Jun 27, 2012
P2, N=333, Completed, Sponsor: Wake Forest Baptist Health
N=514 --> 333 Recruiting --> Completed
- | Enrollment open: Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence (clinicaltrials.gov) - Jun 25, 2012
P2/3, N=100, Recruiting, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed Not yet recruiting --> Recruiting
- Intuniv (guanfacine XR) / Shionogi, Takeda
Enrollment open: Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (clinicaltrials.gov) - Jun 25, 2012
P1, N=20, Recruiting, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting